Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-08

Clinical Trial Update: Role of Repeat Resection in Recurrent Glioblastoma [NA]

View source ↗

Summary

The clinical trial evaluating repeat resection for recurrent glioblastoma has been withdrawn (status: WITHDRAWN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Recurrent Glioblastoma, Glioblastoma - Category | NA | Status: WITHDRAWN